Filing Details

Accession Number:
0001209191-23-032332
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-25 20:21:21
Reporting Period:
2023-05-23
Accepted Time:
2023-05-25 20:21:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1786205 Arcellx Inc. ACLX Biological Products, (No Disgnostic Substances) (2836) 472855917
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1930862 Michelle Gilson C/O Arcellx, Inc.
25 West Watkins Mill Road, Suite A
Gaithersburg MD 20878
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-23 22,428 $0.00 24,189 No 4 M Direct
Common Stock Disposition 2023-05-24 8,554 $42.47 15,635 No 4 S Direct
Common Stock Disposition 2023-05-24 150 $41.64 15,485 No 4 S Direct
Common Stock Disposition 2023-05-25 6,000 $42.77 9,485 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2023-05-23 22,428 $0.00 22,428 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
44,857 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  2. Includes 1,761 shares of Common Stock acquired under the Issuer's 2022 Employee Stock Purchase Plan on May 12, 2023.
  3. Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person.
  4. Represents the weighted average share price of an aggregate total of 6,000 shares sold in the price range of $42.73 to $42.8605 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, the RSUs shall vest annually over three (3) years with a cliff every twelve (12) months on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 23, 2022.